Stryker EV/EBIT SYK

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2010.

Today, Oct 23, 2026: 23.4×
10-year median: 31.9×
Against its 10-year history: 5th; percentile: 0 is its lowest day, 100 its highest
10-year range: 20.8× to 48.4×
Peer median: 21.5×

Stryker's EV/EBIT is 23.4× as of Oct 23, 2026.

That is below its ten-year median of 31.9×, lower than on 95% of days in the last ten years.

Over that time it ranged from 20.8× in Nov 2016 to 48.4× in Jul 2021.

The median for 7 medical device stocks of a similar size is 21.5×.

EV/EBIT over time

median 31.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.4×	20.9×	32.7×
2025	29.6×	28.1×	37.1×
2024	34.7×	31.5×	37.6×
2023	31.9×	28.8×	39.3×
2022	34.4×	29.2×	39.7×
2021	39.8×	34.0×	48.4×
2020	37.4×	21.6×	37.8×
2019	34.3×	25.0×	36.8×
2018	24.6×	24.0×	30.4×
2017	27.3×	22.0×	28.1×
2016	22.4×	19.5×	23.3×
2015	20.8×	19.8×	28.6×
2014	28.3×	20.7×	30.6×
2013	20.8×	10.9×	20.8×
2012	10.4×	9.5×	10.9×
2011	9.4×	8.2×	12.3×
2010	9.7×	8.3×	11.8×

Against its peers

Companies in Medical - Devices nearest Stryker's size, closest first, today.

Company	EV/EBIT
SYKStryker	23.4×
MDTMedtronic	20.7×
ABTAbbott Laboratories	28.2×
BSXBoston Scientific	18.2×
EWEdwards Lifesciences	23.5×
GEHCGE HealthCare Technologies	14.7×
DXCMDexCom	25.3×
ZBHZimmer Biomet	21.5×
Peer median	21.5×

Where Stryker ranks

#8of 13Medical device stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Stryker

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.